5 results on '"Akiko Maruyama"'
Search Results
2. In vitro antibiotic susceptibility profile of Clostridium difficile excluding PCR ribotype 027 outbreak strain in Hungary
- Author
-
Gyula Princz, Marianne Konkoly-Thege, Edit Urbán, Gabriella Terhes, Akiko Maruyama, Elisabeth Nagy, Krisztina Latkóczy, and Lenke Szikra
- Subjects
medicine.drug_class ,Antibiotics ,Erythromycin ,Microbial Sensitivity Tests ,Polymerase Chain Reaction ,Ribotyping ,Microbiology ,Moxifloxacin ,Drug Resistance, Bacterial ,Humans ,Medicine ,Cross Infection ,Hungary ,Clostridioides difficile ,business.industry ,Outbreak ,Clindamycin ,Clostridium difficile ,bacterial infections and mycoses ,Virology ,Anti-Bacterial Agents ,Community-Acquired Infections ,Metronidazole ,Infectious Diseases ,Clostridium Infections ,business ,Rifampicin ,medicine.drug - Abstract
Our study showed the antibiotic susceptibility profile of toxigenic Clostridium difficile isolated from nosocomial and community-acquired CDI between 2008 and 2010. MICs of 200 C. difficile strains were determined using E®test method in the case of erythromycin, clindamycin, moxifloxacin, rifampicin, and metronidazole. All strains were susceptible to metronidazole in the study period. Resistance rates to erythromycin, clindamycin and moxifloxacin were 31%, 29.5%, and 21.5%, respectively. In the case of rifampicin, the MIC range was quite wide, 11.5% of the tested strains proved to be highly resistant (MIC ≥32 μg/ml) to rifampicin. When we compared these results with our earlier findings from 2006 to 2007, only minor changes in susceptibility over the time-periods could be observed in the case of erythromycin, clindamycin, moxifloxacin, and rifampicin, but metronidazole susceptibility did not show changes.
- Published
- 2014
- Full Text
- View/download PDF
3. Relationship between insulin resistance and risk factors for cardiovascular disease in Japanese non-insulin-dependent diabetic patients
- Author
-
Kaori Aoki, Yasue Omori, Hiroyuki Kuroki, Kozo Katsumori, Hiroko Arii, Taro Wasada, Akiko Maruyama, Setsu Saito, and Hajime Hanada
- Subjects
Adult ,Male ,medicine.medical_specialty ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Glucose uptake ,Lipoproteins, VLDL ,Diabetic angiopathy ,High cholesterol ,Endocrinology ,Insulin resistance ,Japan ,Risk Factors ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,Prevalence ,Internal Medicine ,medicine ,Humans ,Insulin ,Obesity ,Triglycerides ,Aged ,business.industry ,Cholesterol, HDL ,Hypertriglyceridemia ,nutritional and metabolic diseases ,Cholesterol, LDL ,General Medicine ,Middle Aged ,medicine.disease ,Apolipoproteins ,Cholesterol ,Diabetes Mellitus, Type 2 ,Cardiovascular Diseases ,Hypertension ,Female ,Insulin Resistance ,business ,Body mass index ,Diabetic Angiopathies - Abstract
To investigate whether a resistance to insulin-stimulated glucose uptake (IR) is associated with the risk factors (RF) for cardiovascular disease (CVD) in non-insulin-dependent diabetic (NIDDM) patients, we determined the degree of IR in 135 adult NIDDM patients who had no advanced diabetic complications. The euglycemic (80 mg/dl) hyperinsulinemic clamp (insulin infusion rate 1.12 mU/kg per min) was performed and the average glucose infusion rate (GIR) during a steady-state euglycemia was determined as a measure of IR. Hypertension was more common among NIDDM patients with an increased IR and was highest in the group of patients with CVD. CVD-RF such as hypertension, hypertriglyceridemia, low HDL-cholesterol and obesity tended to cluster in the NIDDM patients who had lower GIR values and higher fasting IRI levels. GIR values were compared between a set of groups extracted from the 135 NIDDM patients that were matched for age, sex, body mass index and HbA1c levels. The CVD-positive group had the significantly lower GIR value than the CVD-negative group (2.06 +/- 0.66 vs. 3.45 +/- 1.75, P < 0.005). The GIR value was also significantly lower in the hypertriglyceridemic group compared with the normotriglyceridemic group (2.50 +/- 1.36 vs. 4.03 +/- 1.82, P < 0.0005). However, there was no significant difference between the hypertensive and normotensive groups and between the high cholesterol or low HDL-cholesterol groups and their respective control groups. In conclusion, these results suggest that IR contributes to the clustering of CVD-RFs which may accelerate the development of CVD in the subgroup of Japanese NIDDM patients.
- Published
- 1994
- Full Text
- View/download PDF
4. Myopathy with abnormal distribution of dystrophin, growth retardation, mental retardation, and hypospadia
- Author
-
Yutaka Tuchiya, Akiko Maruyama, Ryouichi Sakuta, Ikuya Nonaka, and Toshiro Nagai
- Subjects
Male ,medicine.medical_specialty ,Biopsy ,Fluorescent Antibody Technique ,Dwarfism ,Muscular Dystrophies ,Dystrophin ,Atrophy ,Developmental Neuroscience ,Intellectual Disability ,Internal medicine ,medicine ,Humans ,Child ,Myopathy ,Hypospadias ,Muscle biopsy ,medicine.diagnostic_test ,biology ,business.industry ,Muscles ,Muscle weakness ,medicine.disease ,Staining ,Endocrinology ,Neurology ,Pediatrics, Perinatology and Child Health ,biology.protein ,Immunohistochemistry ,Neurology (clinical) ,medicine.symptom ,DNA Probes ,business ,Immunostaining ,Adrenal Insufficiency - Abstract
A 9-year-old boy with severe growth retardation, mild mental retardation, and hypospadia had a high serum CK level without muscle weakness and atrophy. Muscle biopsy revealed a moderate variation in fiber size with a few necrotic and scattered regenerating fibers. Although muscle membranes were clearly stained by immunostaining with antibody to dystrophin, N-terminal region (2-5E2), fibers in groups revealed striking, intense staining with the other antibody, C-terminal region (4C5), suggesting some aberration of the dystrophin gene near the C-terminal area. His unique clinical features, as well as myopathy, are reported, although further study is necessary to clarify the relationship between the anomalous conditions and dystrophin abnormalities.
- Published
- 1993
- Full Text
- View/download PDF
5. Scoliosis associated with central core disease
- Author
-
Masakazu Takemitsu, Ikuya Nonaka, Akiko Maruyama, Toshiro Nagai, and Yutaka Tsuchiya
- Subjects
Adult ,medicine.medical_specialty ,Scoliosis ,Myopathies, Nemaline ,Biceps ,Atrophy ,Developmental Neuroscience ,medicine ,Humans ,Child ,Kyphoscoliosis ,Rachis ,business.industry ,Muscles ,Muscle weakness ,General Medicine ,medicine.disease ,Congenital myopathy ,Surgery ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Female ,Neurology (clinical) ,medicine.symptom ,business ,Central core disease - Abstract
A 12-year-old Japanese girl who had progressive severe scoliosis but with minimal muscle weakness in the extremities was found to have central core disease. In her muscle biopsies obtained from the biceps brachii and paraspinous muscles, there was type 1 fiber atrophy and predominance, as is commonly seen in congenital myopathies, but the core structure was identified only in the former. To determine whether scoliosis is a prominent feature of this disease, we reviewed 10 patients with central core disease in our laboratory and found 6 ambulant patients who had mild-to-moderate scoliosis. Since kyphoscoliosis becomes prominent as muscle weakness progresses to loss of ambulation in most muscle diseases, this disproportionate spinal involvement in central core disease appears to be a striking feature. All patients with ‘idiopathic’ scoliosis deserve a careful neurological evaluation, even if they have minimal muscle symptoms in the extremities.
- Published
- 1994
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.